7 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
4/11/2020 #Drugs ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management ... #MGH
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
#Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology # ... comparison #table ... #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
medications, with ... kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... If you see a patient ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... /m2, 350 mg/m2, ... and 550 mg/m2, respectively ... ) and initiate treatment ... hypertension, diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... the type of and indication ... Diabetes regimen ... one post op Cardiology ... medical and surgical management
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Infections in HIV-AIDS Indications ... with ARV (see Table ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology